Misoprostol (Cytotec) for Early Medication Abortion: Efficacy, Risks, Protocol

Misoprostol (Cytotec) is a prostaglandin E1 analog used for medication abortion up to 12–13 weeks (often combined with mifepristone).

Mechanism

  • Cervical ripening (softening, dilation)
  • Uterine contractions → expulsion

Regimen (WHO/ACOG)

  • Combined: Mifepristone 200 mg PO → 24–48h later Misoprostol 800 mcg buccal/vaginal
  • Misoprostol-only: 800 mcg buccal/vaginal q3h × 2–3 doses (lower efficacy)

Efficacy

>95% complete abortion with combined regimen; slightly lower with misoprostol alone.

Side Effects

  • Expected: cramping, bleeding (heavier than menses), nausea, diarrhea, fever/chills
  • Rare: incomplete abortion (2–5%), heavy hemorrhage, infection, uterine rupture (<0.1%)

Contraindications

Ectopic pregnancy, IUD in situ, anticoagulation, severe anemia, cardiovascular disease, allergy.

Follow-Up

Clinical assessment ± hCG trend ± ultrasound at 1–2 weeks to confirm completion.

Pregnancy & Health - Related Articles